There are 2867 resources available
923P - Molecular classification of cancers of unknown primary expands and refines treatment options
Presenter: Daniel George
Session: Poster session 10
924P - BLEACH&STAIN, a novel multiplex fluorescence immunohistochemistry framework that facilitates a fast high-throughput analysis of >15 biomarkers in more than 3000 human carcinomas
Presenter: Elena Bady
Session: Poster session 10
925P - Analytical performance of a next-generation sequencing (NGS) assay kit for assessing homologous recombination deficiency (HRD) from solid tumor samples
Presenter: Li Liu
Session: Poster session 10
926P - Utility of point-of-care genomic profiling in the diagnosis and treatment of cancer of unknown primary
Presenter: Xin Wang
Session: Poster session 10
927P - Awareness & obscurity: Demystifying genomic profiling in real-world practice for the members of Turkish Society of Medical Oncology (TSMO)
Presenter: Ertugrul Bayram
Session: Poster session 10
1365P - The impact of PSMA-positive circulating tumor cells in men with metastatic castrate-resistant prostate cancer (mCRPC)
Presenter: Santosh Gupta
Session: Poster session 10
1366P - Impact of COVID-19 on prostate cancer diagnosis and treatment
Presenter: Rebecca Leszczynski
Session: Poster session 10
1367P - JNJ-70218902 (JNJ-902), a TMEFF2 x CD3 bispecific antibody, in prostate cancer: Initial results from a phase I dose escalation study
Presenter: Emiliano Calvo
Session: Poster session 10
1368P - TALAPRO-1: Talazoparib monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) – Exploration of tumor genetics associated with prolonged benefit
Presenter: Johann de Bono
Session: Poster session 10
1369P - Biochemical outcomes from ARTO trial (NCT03449719) a phase II randomized trial testing association between abiraterone acetate and stereotactic body radiation therapy in castrate-resistant prostate cancer patients
Presenter: Giulio Francolini
Session: Poster session 10